Foxp3 inhibits HDAC1 activity to modulate gene expression in human T cells

Virology

Volumn 421, Issue 1, 2011, Pages 12-18

  Holmes, Derek ^a,b   Gao, Jianmei ^a   Su, Lishan ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Foxp3; HDAC; HIV 1; LTR; Treg

Indexed keywords

HISTONE DEACETYLASE 1; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE;

CELL LINE; DOWN-REGULATION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, VIRAL; HISTONE DEACETYLASE 1; HIV INFECTIONS; HIV-1; HUMANS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; T-LYMPHOCYTES;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80055077466     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.09.002     Document Type: Article

References (29)

1. Chen L., Fischle W., Verdin E., Greene W.C. Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 2001, 293:1653-1657.
2. Coffield V.M., Jiang Q., Su L. A genetic approach to inactivating chemokine receptors using a modified viral protein. Nat. Biotechnol. 2003, 21:1321-1327.
3. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 2003, 4:330-336.
4. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005, 22:329-341.
5. Grant C., Oh U., Fugo K., Takenouchi N., Griffith C., Yao K., Newhook T.E., Ratner L., Jacobson S. Foxp3 represses retroviral transcription by targeting both NF-kappaB and CREB pathways. PLoS Pathog. 2006, 2:e33.
6. He J., Landau N.R. Use of a novel human immunodeficiency virus type 1 reporter virus expressing human placental alkaline phosphatase to detect an alternative viral receptor. J. Virol. 1995, 69:4587-4592.
7. Holmes D., Knudsen G., Mackey-Cushman S., Su L. FoxP3 enhances HIV-1 gene expression by modulating NFkappaB occupancy at the long terminal repeat in human T cells. J. Biol. Chem. 2007, 282:15973-15980.
8. Jiang Q., Su H., Knudsen G., Helms W., Su L. Delayed functional maturation of natural regulatory T cells in the medulla of postnatal thymus: role of TSLP. BMC Immunol. 2006, 7:6.
9. Jiang Q., Zhang L., Wang R., Jeffrey J., Washburn M.L., Brouwer D., Barbour S., Kovalev G.I., Unutmaz D., Su L. FoxP3+CD4+ regulatory T cells play an important role in acute HIV-1 infection in humanized Rag2-/-gammaC-/- mice in vivo. Blood 2008, 112:2858-2868.
10. Joshi A., Garg H., Tompkins M.B., Tompkins W.A. Preferential feline immunodeficiency virus (FIV) infection of CD4+ CD25+ T-regulatory cells correlates both with surface expression of CXCR4 and activation of FIV long terminal repeat binding cellular transcriptional factors. J. Virol. 2005, 79:4965-4976.
11. Khattri R., Cox T., Yasayko S.A., Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 2003, 4:337-342.
12. Lahm A., Paolini C., Pallaoro M., Nardi M.C., Jones P., Neddermann P., Sambucini S., Bottomley M.J., Lo Surdo P., Carfi A., et al. Unraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:17335-17340.
13. Laughlin M.A., Zeichner S., Kolson D., Alwine J.C., Seshamma T., Pomerantz R.J., Gonzalez-Scarano F. Sodium butyrate treatment of cells latently infected with HIV-1 results in the expression of unspliced viral RNA. Virology 1993, 196:496-505.
14. Li B., Samanta A., Song X., Iacono K.T., Brennan P., Chatila T.A., Roncador G., Banham A.H., Riley J.L., Wang Q., et al. FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease. Int. Immunol. 2007, 19:825-835.
15. Miller-Jensen K., Janes K.A., Brugge J.S., Lauffenburger D.A. Common effector processing mediates cell-specific responses to stimuli. Nature 2007, 448:604-608.
16. Moreira J.M., Scheipers P., Sorensen P. The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses. BMC Cancer 2003, 3:30.
17. Ono M., Yaguchi H., Ohkura N., Kitabayashi I., Nagamura Y., Nomura T., Miyachi Y., Tsukada T., Sakaguchi S. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 2007, 446:685-689.
18. Oswald-Richter K., Grill S.M., Shariat N., Leelawong M., Sundrud M.S., Haas D.W., Unutmaz D. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol. 2004, 2:E198.
19. Quivy V., Adam E., Collette Y., Demonte D., Chariot A., Vanhulle C., Berkhout B., Castellano R., de Launoit Y., Burny A., et al. Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies. J. Virol. 2002, 76:11091-11103.
20. Rahman M.M., Kukita A., Kukita T., Shobuike T., Nakamura T., Kohashi O. Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages. Blood 2003, 101:3451-3459.
21. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995, 155:1151-1164.
22. Selliah N., Zhang M., White S., Zoltick P., Sawaya B.E., Finkel T.H., Cron R.Q. FOXP3 inhibits HIV-1 infection of CD4 T-cells via inhibition of LTR transcriptional activity. Virology 2008, 381:161-167.
23. Sengupta N., Seto E. Regulation of histone deacetylase activities. J. Cell. Biochem. 2004, 93:57-67.
24. Steger D.J., Eberharter A., John S., Grant P.A., Workman J.L. Purified histone acetyltransferase complexes stimulate HIV-1 transcription from preassembled nucleosomal arrays. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:12924-12929.
25. Tao R., de Zoeten E.F., Ozkaynak E., Chen C., Wang L., Porrett P.M., Li B., Turka L.A., Olson E.N., Greene M.I., et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 2007, 13:1299-1307.
26. Van Lint C., Emiliani S., Verdin E. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr. 1996, 5:245-253.
27. Wu Y., Borde M., Heissmeyer V., Feuerer M., Lapan A.D., Stroud J.C., Bates D.L., Guo L., Han A., Ziegler S.F., et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 2006, 126:375-387.
28. Yin L., Laevsky G., Giardina C. Butyrate suppression of colonocyte NF-kappa B activation and cellular proteasome activity. J. Biol. Chem. 2001, 276:44641-44646.
29. Ziegler S.F. FOXP3: of mice and men. Annu. Rev. Immunol. 2006, 24:209-226.